Login to Your Account

Biotechs Racing to Produce Radiation Exposure Drugs

By Mari Serebrov

Monday, March 21, 2011
WASHINGTON – Concerns about a nuclear meltdown in Fukushima, Japan, are producing a global reaction as countries rethink their use of nuclear technology and frightened consumers stock up on potassium iodide tablets, one of the only drugs available that can ward off a few of the health effects of exposure to excessive radiation.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription